Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMC 98665)

Published in Infect Immun on September 01, 2001

Authors

N K Fry1, S Neal, T G Harrison, E Miller, R Matthews, R C George

Author Affiliations

1: Respiratory and Systemic Infection Laboratory, PHLS Central Public Health Laboratory, London, United Kingdom. nfry@phls.org.uk

Articles citing this

Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol (2004) 2.58

Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol (2009) 1.48

Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis (2014) 1.43

Whooping cough--a continuing problem. BMJ (2002) 1.43

Small mutations in Bordetella pertussis are associated with selective sweeps. PLoS One (2012) 1.35

Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34

Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol (2005) 1.23

Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun (2010) 1.17

Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Clin Vaccine Immunol (2007) 1.14

Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10

Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol (2007) 1.05

Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05

Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis (2010) 0.98

Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. PLoS One (2011) 0.94

SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One (2011) 0.93

Studies on Prn variation in the mouse model and comparison with epidemiological data. PLoS One (2011) 0.91

Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol (2002) 0.89

Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis (2006) 0.88

Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants. J Clin Microbiol (2004) 0.87

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol (2012) 0.86

Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol (2005) 0.83

Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82

Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013. Eur J Clin Microbiol Infect Dis (2014) 0.78

Pertussis in infants less than 6 months of age and household contacts, Italy, April 2014. Hum Vaccin Immunother (2015) 0.77

Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea. Osong Public Health Res Perspect (2011) 0.77

Seroepidemiology of Bordetella pertussis infections in the twin cities of Pakistan. N Am J Med Sci (2009) 0.76

Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients. Avicenna J Med Biotechnol (2014) 0.76

Genetic Variation of Bordetella pertussis in Austria. PLoS One (2015) 0.76

Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran. Int J Mol Cell Med (2015) 0.75

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH. Br Med J (1963) 6.83

Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun (1998) 3.76

Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A (1989) 3.13

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis (2000) 3.09

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine (1998) 3.07

Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24

Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun (1999) 2.09

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis (2000) 2.04

Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00

Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell (1997) 1.93

Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep (1995) 1.81

Return of epidemic pertussis in the United States. Pediatr Infect Dis J (1994) 1.77

Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur J Immunol (1991) 1.67

Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health (2000) 1.37

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine (1999) 1.33

The science and fiction of pertussis vaccines. Pediatrics (1999) 1.13

An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines. Vaccine (1999) 1.00

Pertussis immunisation in Europe - the situation in late 1999. Euro Surveill (2000) 0.95

WHO Expert Committee on Biological Standardization. Thirtieth report. World Health Organ Tech Rep Ser (1979) 0.90

Whooping cough notifications continue to fall: young unimmunised infants remain at highest risk. Commun Dis Rep CDR Wkly (1999) 0.81

Articles by these authors

The action of light on the eye: Part I. The discharge of impulses in the optic nerve and its relation to the electric changes in the retina. J Physiol (1927) 64.51

The action of light on the eye: Part III. The interaction of retinal neurones. J Physiol (1928) 33.08

The action of light on the eye: Part II. The processes involved in retinal excitation. J Physiol (1927) 19.93

Vancomycin-resistant enterococci. Lancet (1988) 11.27

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10

Fingerprinting Candida albicans. J Immunol Methods (1986) 6.90

The new measles campaign. BMJ (1994) 6.59

Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1989) 5.65

BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax (2009) 5.23

Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22

Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86

Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60

Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56

Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28

Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18

Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10

High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect (1989) 3.95

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93

Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev (1990) 3.82

Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62

False positive reactions in the indirect fluorescent antibody test for Legionnaires' disease eliminated by use of formolised yolk-sac antigen. Ann Intern Med (1979) 3.59

Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19

SEX DIFFERENCES IN KIDNEY MORPHOLOGY AND CHLOROFORM NECROSIS. Science (1945) 3.18

Surveillance of antibody to measles, mumps, and rubella by age. BMJ (1988) 3.11

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10

Treatment of Early Mammary Carcinoma: A Cooperative International Study. Ann Surg (1963) 3.07

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ (1996) 2.92

Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86

Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis (2002) 2.84

Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1990) 2.82

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81

Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81

The development of a concise questionnaire designed to measure perceived outcomes on the issues of greatest importance to patients. Br Dent J (2012) 2.71

Proposals to unify the genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. nov., Bartonella peromysci comb. nov., and three new species, Bartonella grahamii sp. nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov. Int J Syst Bacteriol (1995) 2.68

Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol (1974) 2.57

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57

Rubella vaccination in the UK: time for a complete strategy. Lancet (1985) 2.54

Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51

Varicella-zoster virus epidemiology--a changing scene? J Infect Dis (1996) 2.48

Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48

Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48

Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48

Shift in age in chickenpox. Lancet (1993) 2.46

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet (1994) 2.43

Cell position and light influence C4 versus C3 patterns of photosynthetic gene expression in maize. EMBO J (1988) 2.37

Diagnosis of Legionella pneumophila infections by means of formolised yolk sac antigens. J Clin Pathol (1982) 2.37

Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA. J Med Microbiol (2001) 2.35

Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33

Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32

The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32

Enterococcus faecium with high-level resistance to gentamicin. Lancet (1991) 2.28

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26

Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis (1999) 2.16

Varicella in maternity units. Lancet (1990) 2.16

Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) (1987) 2.13

The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis (1999) 2.04

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem (2000) 2.02

Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol (1995) 2.00

Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99

Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol (1993) 1.95

A method for typing strains of Legionella pneumophila serogroup 1 by analysis of restriction fragment length polymorphisms. J Med Microbiol (1990) 1.93

Human amnion as an adjunct in wound healing. Lancet (1980) 1.92

A rapid microagglutination test for the diagnosis of Legionella pneumophila (serogroup 1) infection. J Clin Pathol (1982) 1.90

Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89

Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88

Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.88

Vasopressin in prevention of lumbar puncture headache. Br Med J (1968) 1.85

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ (2010) 1.83

Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80

The Support of Research in Medical and Allied Fields for the Period 1946 through 1951. Science (1952) 1.80

Identification of cryptosporidium oocysts by monoclonal antibody. Lancet (1987) 1.79

Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79

Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol (2002) 1.77

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75

A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory. J Clin Microbiol (1997) 1.74

Evaluation of an oral health scoring system by dentists in general dental practice. Br Dent J (2003) 1.70

Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69

Detection of Legionella pneumophila using a real-time PCR hybridization assay. J Clin Microbiol (2000) 1.69

Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA (1971) 1.68

Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child (1984) 1.67

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67

The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66

Antimicrobial resistance amongst enterococci isolated in the United Kingdom: a reference laboratory perspective. J Antimicrob Chemother (1993) 1.65

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65

Grahamella in small woodland mammals in the U.K.: isolation, prevalence and host specificity. Ann Trop Med Parasitol (1994) 1.64

Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract (2001) 1.64

Surveillance of symptoms following MMR vaccine in children. Practitioner (1989) 1.63

Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62

Evaluation of a genus-specific monoclonal antibody in an amplified enzyme-linked immunoassay in the detection of Chlamydia in urine samples from men. Sex Transm Dis (1990) 1.60